GB1530138A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB1530138A
GB1530138A GB41872/75A GB4187275A GB1530138A GB 1530138 A GB1530138 A GB 1530138A GB 41872/75 A GB41872/75 A GB 41872/75A GB 4187275 A GB4187275 A GB 4187275A GB 1530138 A GB1530138 A GB 1530138A
Authority
GB
United Kingdom
Prior art keywords
oct
pharmaceutical composition
diglucoside
glycerophosphoric
psychotropic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB41872/75A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of GB1530138A publication Critical patent/GB1530138A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1530138 Phospholipids INSTITUT PASTEUR 13 Oct 1975 [14 Oct 1974] 41872/75 Heading C2P [Also in Division A5] Diglucoside derivatives bearing glycerophosphoric functions of either of the following formulae: are prepared by extraction from bacteria. Pharmaceutical compositions for oral, parenteral, rectal and external administration, and having anti-infective, antibacterial, antiviral, antiparasitic, psychotropic and hypolipemic activity, comprise a compound supra and carrier.
GB41872/75A 1974-10-14 1975-10-13 Pharmaceutical composition Expired GB1530138A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7434400A FR2287901A1 (en) 1974-10-14 1974-10-14 IMMUNOSTIMULANT MEDICINAL PRODUCT CONTAINING OSE DERIVATIVE OR PHOSPHORYL POLYOSE

Publications (1)

Publication Number Publication Date
GB1530138A true GB1530138A (en) 1978-10-25

Family

ID=9144037

Family Applications (1)

Application Number Title Priority Date Filing Date
GB41872/75A Expired GB1530138A (en) 1974-10-14 1975-10-13 Pharmaceutical composition

Country Status (9)

Country Link
AU (1) AU8570375A (en)
BE (1) BE834493A (en)
CA (1) CA1063052A (en)
DE (1) DE2546001C3 (en)
FR (1) FR2287901A1 (en)
GB (1) GB1530138A (en)
IL (1) IL48293A (en)
NL (1) NL7512053A (en)
ZA (1) ZA756462B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372949A (en) 1979-03-05 1983-02-08 Toyama Chemical Co., Ltd. Treatment of cancer with carcinostatic and immunostimulating agent containing lysophospholipid and phospholipid
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
US4885285A (en) * 1984-09-13 1989-12-05 Ciba-Geigy Corporation Phosphorus compounds, processes for their manufacture, and their use
EP0516914A2 (en) * 1991-06-07 1992-12-09 MEDIOLANUM FARMACEUTICI s.r.l. Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585762A (en) * 1982-07-30 1986-04-29 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, processes for use thereof and pharmaceutical composition of the same
FR2596651B1 (en) * 1986-04-08 1989-11-10 Centre Nat Rech Scient NOVEL LIPOSOMES BASED ON PHOSPHATIDYLINOSITOLMANNOSIDES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1244546B (en) * 1991-02-01 1994-07-15 Mediolanum Farmaceutici Spa ANALOGUES OF PHOSPHATIDYLINITITOL INHIBITORS OF PHOSPHOLIPASE C PHOSPHATIDYLINITITOL-SPECIFIC

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793260A (en) * 1971-12-24 1973-06-22 Pasteur Institut IMMUNOSTIMULANT AGENT, MEDICINES CONTAINING IT AND METHOD FOR MANUFACTURING SUCH IMMUNOSTIMULANT AGENT

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372949A (en) 1979-03-05 1983-02-08 Toyama Chemical Co., Ltd. Treatment of cancer with carcinostatic and immunostimulating agent containing lysophospholipid and phospholipid
US4885285A (en) * 1984-09-13 1989-12-05 Ciba-Geigy Corporation Phosphorus compounds, processes for their manufacture, and their use
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
EP0516914A2 (en) * 1991-06-07 1992-12-09 MEDIOLANUM FARMACEUTICI s.r.l. Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation
EP0516914A3 (en) * 1991-06-07 1993-02-24 Mediolanum Farmaceutici S.P.A. Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation

Also Published As

Publication number Publication date
AU8570375A (en) 1977-04-21
DE2546001C3 (en) 1980-06-19
ZA756462B (en) 1976-09-29
FR2287901A1 (en) 1976-05-14
DE2546001B2 (en) 1979-07-19
DE2546001A1 (en) 1976-04-15
BE834493A (en) 1976-04-14
NL7512053A (en) 1976-04-20
IL48293A0 (en) 1975-12-31
FR2287901B1 (en) 1978-07-21
CA1063052A (en) 1979-09-25
IL48293A (en) 1979-01-31

Similar Documents

Publication Publication Date Title
GEP20002210B (en) Acridine Derivatives
ES457417A1 (en) Hypotensive 3,4-dihydro-2,2-dimethyl-4-amino-2H-benzo[b]pyran-3-ols
GB1392275A (en) Therapeutic compositions
GB1476827A (en) Vincaminic acid esters
GB1530138A (en) Pharmaceutical composition
GB1388358A (en) Taste-improving formulations of oral penicillins
ES439927A1 (en) 7-Methoxy-6-thiatetracyclines and their preparation
GB1461032A (en) Erthromycylamine derivatives
GB1348089A (en) 1-oxa-3,8diaza spiro-4,5-decane derivatives and processes for preparing them
ES375203A1 (en) Benzothiazepine derivatives
GB1274652A (en) Adamantanyl-alkylamine derivatives and their preparation
GB1352257A (en) Pyridyltriazoles their preparation and compositions containing them
GB1405767A (en) Method formulation and pharmaceutical composition for reducing plasma lipid levels
GB1514225A (en) Paracetamol derivatives
GB1391862A (en) Benzodiazepines
ES367521A1 (en) Benzothiadiazole compounds
GB1413484A (en) Scopolamine derivatives
GB1246117A (en) Pharmaceutical preparations containing glucose compounds, glucose derivatives and process for their manufacture
GB1271519A (en) Improvements in or relating to derivatives of phloroglucinol
GB1424611A (en) Pharmaceutical compositions
GB1397675A (en) Proline compounds
GB1287506A (en) Arginine-potassium phosphocitro-glutamate
GB1169074A (en) Improvements in or relating to Hepato-Protective Drugs
ES469648A1 (en) Oleandomycin derivatives
GB1292745A (en) 4-alkyl-diphenylmethoxy-alkylamines and acid addition salts and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee